Kims Nursing Assistance

The Existence of Nursing Job Descriptions and Why is There a Need For It
By Cheryl Forbes

The secret behind being good at what you do is knowing what you are doing. Familiarization is the key to being the best at what you do. When you already know what you are supposed to do at work, being creative and inventive when it comes to daily tasks follows immediately especially if you want to improve your skills. How to improve your work immediately follows especially when you want to improve your craft.

This is the reason why job descriptions are given as soon as you sign your employment contract. So that you will somehow be familiar with what is expected of you. You should never expect to be spoon fed at work. Read your job description, be familiar with it. Some may not automatically give you your job description and so do not be afraid to ask for it. When you have signed your employment contract, your job description immediately becomes your right as an employee.

People never thought that nurses also need their nursing job description. It maybe because they seem to be doing one job and that is to assist the doctor at whatever the doctors are doing at the moment. What we do not know is they also have different tasks depending on the department or section where they are in.

A military nurse definitely has skills that may somehow differ from a nurse that works in a hospital. There are also other kinds of nurses such as a nurse that has an informatics job, a psychiatric nurse and others. Each and every specialization is different but there are also skills that they all nurses have.

Cheryl Forbes owns as well as operates the popular website www.nursing-recruit.org

Article Source: http://EzineArticles.com/?expert=Cheryl_Forbes
http://EzineArticles.com/?The-Existence-of-Nursing-Job-Descriptions-and-Why-is-There-a-Need-For-It&id=1648029

Cosmetic Surgery And The Dangers

Eating a 600-calorie breakfast rich in carbohydrates and protein helps dieters lose more weight long term than eating a modest breakfast and following a lower-carb eating plan, according to a new study.

More: continued here

Laquinimod is a novel immunomodulatory agent developed as a potential disease-modifying treatment for multiple sclerosis (MS). In a 24-week double-blind phase II study, 0.3 mg/d of laquinimod was reported to be well tolerated and effective in suppressing the formation of MRI-active lesions in relapsing-remitting MS. This current phase II study funded by Teva tested the efficacy of two doses of laquinimod on MRI-monitored disease activity and safety.The 36-week, double-blind study involved 306 patients aged 18–50 years, with one or more relapses in the year before entry and at least one gadolinium enhancing (GdE) lesion on screening MRI. They were randomised to placebo (n=102), laquinimod 0.3mg/d (n=98), or 0.6mg/d (n=106). Brain MRI scans and clinical assessments were conducted at week -4, baseline, and monthly from week 12 to week 36. The primary outcome was the cumulative number of GdE lesions at weeks 24, 28, 32, and 36. Compared with placebo in the intention-to-treat cohort, treatment with laquinimod 0.6mg/d showed a 40.4% reduction of the baseline adjusted mean cumulative number of GdE lesions per scan on the last 4 scans (mean 4.2 vs. 2.6, p=0.0048); treatment with 0.3 mg/d showed no significant effects (3.9 vs. placebo, p=0.6740). Both doses of laquinimod were well tolerated, with some transient and dose-dependent increases in liver enzymes; a case of Budd-Chiari syndrome occurred after 1 month of exposure to the 0.6 mg dose in a patient with underlying hypercoagulability.The researchers conclude from these preliminary findings that laquinimod at a dose of 0.6mg/d per day reduced MRI-measured disease activity in patients with relapsing-remitting MS. An accompanying comment article notes that though no statistically significant differences were seen in relapse rate or clinical disability in this short trial, it was not powered to detect such differences. It discusses whether the development of MRI gadolinium-enhanced lesions is a good surrogate outcome and questions why the 0.3mg dose was not effective and if the limited duration of the study was the principal reason that relapses were not affected. A phase III trial addressing these issues is underway. It was also highlighted that though the investigators did not encounter the serious safety issues seen in the clinical trial of the structurally related linomide, which was abandoned after major adverse events, continued vigilance is needed because serious adverse effects are commonly not evident until phase III studies are started (as with linomide) or until after approval (as with natalizumab).

More: continued here

From the desk of Dr Magne, author of Cancer Free For Life There is an epidemic and it is dangerous. But its face is so subtle that most of us have a hard time believing it. Its called ASPARTAME. When the temperature of Aspartame exceeds 86 degrees F, the wood alcohol in aspartame coverts to formaldehyde and then to formic acid. In the case of systemic lupus, it has become almost as rampant as multiple sclerosis, especially Diet Coke and Diet Pepsi drinkers. The victims usually drink …

More: continued here

Condition:   Prophylaxis Herpes Simplex
Interventions:   Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
Sponsor:   GlaxoSmithKline
Completed - verified June 2008

More: continued here
Powered by SmartRSS

Read the full story on Mosby’s Nursing Consult:CORRECTION: Understanding Fracture Risk Is Crucial in Early Postmenopause Treatment of Low Bone Mass

More: continued here
Powered by SmartRSS

Read the full story on Mosby’s Nursing Consult:Elderly Patients With Metastatic Esophageal or Gastric Cancer Have Survival Comparable With Younger Patients

More: continued here

Money might buy happiness for some, but for most people having strong family ties is a much bigger predictor of contentment than income, a new study shows.

More: continued here
Powered by SmartRSS

If you are being treated for type 2 diabetes, are you also at a greater risk of being depression? A new study looks at the link, suggesting the two may go hand in hand.

More: continued here